London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Started: David6576, 28 May 2024 13:49
Last post: roger65, 17 Jun 2024 12:40
Hey bunsen, I wonder what the 'one or two' - difficult to tell the difference between 1 and 2 - employees are doing this week to earn their £500k worth of annual salaries. There's Cricket T20 world cup, Wimbledon coming up, Euros, US Open just done...I hope they're not feeling too stressed.
Is there a deadline by which this company has to be wound up now that it's just a cash shell for a rto?
OVB up 11% on aquis due to 200k share buy
Just nipped on to see no one interested here.
If you believe bunsen then one or two people are taking salaries of £250k each for doing absolutely nothing and they have £1.5m in the bank. If I were then I’d continue to do nothing for another 2 or 3 yrs until the money runs out. Nice work if you can get it. Seriously though, if you bribe that bunsen AND think this is worth throwing money at then I’d question your judgement.
Imo cash is more like £700k and they’re paying the Directors fees for doing nothing and it’s just a case of waiting to see if anyone offers a RTO . Being realistic the chances are slim so those is a punt with very long odds..
Omg bunsen I just can’t believe you posted that tripe. It’s embarrassing - just a couple of salaries so only buying £500k a year….had to stifle a belly laugh at that. But no, seriously, half a million quid for one or two salaries - I think that’s what the BoD told you - is perfectly reasonable.
Cretinous. Just imbecilic . Extraordinary post. Yes, I should definitely throw money into this. Banging head against brick wall emoji
My opinion 2x cash yes. They had £2.4m I think a year ago. Costs are minimal, literally paying for what? Couple salaries what else? No trials or anything. So say burning £500k a year? Absolute tops IMO. Leaves say £1.9m but I could be wrong about the £2.4m. So leaving lots of room for error, say £1.5m. That’s double and some from current levels. DYOR
Skiers long gone
The size of the spread here surely clowns like skier1 made nothing out of this lol
Cando too late every one has gone. The pump and dump is over. Sorry to say.
Pump and dump, now comes the huge losses like 151295 pays 1.37p sells for 0.98p
Now’s the time for the buys after the stop losses and daily takers have been in
Started: Thecodger, 27 Jan 2024 09:06
Last post: Spondulicks, 24 Apr 2024 18:16
Good day today
So I estimate cash position @ £2.1m vs a market cap of £700k
That’s a 200% gain to market cap & still be undervalued
Current costs will be a fraction of what they were before as there are no studies or live business occurring
Ovoca Bio are essentially a cash shell
On the day of the failed P2 studies, the share price dropped to 2.75p. Today, you can buy it under 1p
Undervalued
So I estimate cash position @ £2.1m vs a market cap of £700k
That’s a 200% gain to market cap & still be undervalued
Current costs will be a fraction of what they were before as there are no studies or live business occurring
Ovoca Bio are essentially a cash shell
On the day of the failed P2 studies, the share price dropped to 2.75p. Today, you can buy it under 1p
Multibagger
Hi the codger
You’re spot on there my friend!
Will explain my reasoning tomorrow or Monday
Yes, agree, 100% – there aren’t many no-brainers, but this is certainly one for me
Have a great evening
Decided to take a punt at 0.8779 .considering the cash position, it's a nobrainer
Rick. I have held OVB for nearly 6 years. In that time it has spiked 100-300% maybe 3-5 times which I have traded. I obviously lost a few quid on the trial results 14p down to current 0.6p but made more on the run to 14p from 6p. This is overdue a update, I'm not hopeful of a positive one because of the delay, they have assets in Russia but can they sell them, they once had a ton of cash but is any left now, the sector has been decimated with stocks running out money, struggling to raise money and delisting etc etc.
PRICK123, your pumping is needed on the NTOG board, it’s dropped over 12%
Good help you if davey50 pence has arrived
0.6-0.9p jeezus gets worse, early buyers already sold out by the looks of things. I cannot believe how long the company has gone without a update.
It was actually 0.9p bid earlier, they have dropped from 0.9p to 0.7p bid on no sales at all.
Started: Pidster, 21 Mar 2024 12:36
Last post: bunsenburner123, 21 Mar 2024 12:59
Don’t know mate
MMs just rugged the bid
They’ve just risen it back over 10% on 0 volume
They’re looking for shares. Good sign
Why is the spread so high now ? Thx JP
Started: Thecodger, 29 Jan 2024 10:06
Last post: Pidster, 20 Mar 2024 10:25
Sorry wrong board
You’re going to miss out Petroinvestor!!!
Bought In yesterday, very low price now !
Absolutely, punters will wake up to this sooner rather than later. Any day now surely an rns on progress
Started: Billthebank, 4 Jan 2024 21:45
Last post: Billthebank, 4 Jan 2024 21:45
This is a long term hold and it doesn't matter what your entry is.Just read the RNS Buy hold and wait.Review in 6/9 months
Last post: Thecodger, 4 Nov 2023 09:03
The value here is plain to see. Taymura adds possible future cash.definately worth a small punt and I have taken one .59k at 1.28
They mentioned this name in interims, turns out they are owed £6 mil in assets. But this has been going on a very long time.
But it just adds a extra edge to the value at this distressed level, with current cash double the market cap. The chances the two 20% directors could sell up and some new heavyweights come on board and this becomes a cash shell there's always a chance of that. Orenetide could still not be ruled out but maybe it's best to write that off unless they discover a weird reason why it failed in recent trials but sailed through the previous trials.
All in all I think this is cheap down here, possible 100% to be made on a bounce and any surprise Rns could deliver more but know the risks as always
Last post: KoR_Wraith, 25 Sep 2023 17:02
"Need a 3rd group
Peptide
Placebo
Nothing
Maybe it’s so happened that the peptide and placebo group both increased the results Vs a nothing group baseline."
I don't think you understand how clinical trials work...
Russian medical trials are treated with mistrust for good reason. More likely the Russian trial was the one with the unusual results.
Agree, from last RNS it’s very likely they will want to re-run as the results go against the norm…it doesn’t make sense!
I agree. They are reviewing everything atm. If it can be determined that the testing was done anyways incorrectly then a retest will occur. It just does not add up that the drug can be perfectly ok in one area then not in another.
Reminds me of Elan's Tysabri which got a bad result at the start then retested and their shares rocketed. Could easily be the same here. Absolutely no point in selling now. News will happen soon.
Still radio silence from BoD…but can’t be long now. Whilst SP is rock bottom, any positive news here and this should rocket..
There is a big spread this needs to be cut down to bring traders back in.
Started: kkrriiss, 12 Sep 2023 10:00
Last post: scmdcyp, 12 Sep 2023 10:01
This is so low must be worth a punt.
Last chance in the 2s today
Last post: davey50, 7 Sep 2023 08:27
Interesting. I think everybody agrees something is not right. Sails thru a phase 3 trial in Russia and then totally flops a phase 2 in Oz/Nz when it should have been a slam dunk, that is why I think it's a strong hold at 2p because there is still hope and if not there is a lot of cash and tax losses with big shareholders so they can always do something else down the cash shell route
Ovoca Bio (#OVB) was highly speculative. Bizarre result given previous positive trials. Data still to be analysed. #STX had a test fail in 2018 with Accrufer but found some patients had violated protocols. Accrufer now on sale in USA
This has Fallen way way to much. in for 100k ...big bounce soon .imo
Could be blue....soon
Interesting post. Certainly makes you think there is more to this being a total duster.
Added 150k at 2p, if it spikes I will trade them
Just looking at how they measured the outcome, and i see the "The Female Sexual Distress Scale-Revised (FSDS-R;revised 2005)" for another co (google) and "Female Sexual Function Index", its just a questionaire, a survey, nothing scientific measuring bloods levels / phyical changes (for the particular ones i saw on google anyway) so its all down to interpretation.
How many of these questions could have been answered technically incorrect because of a degree of embarrassment, prudishness, sensitivity, guilt, its not even a 1-10 or 1-100 score its 1-4, even if they said 2 at start then 3 after its a pointless scale of differential when so small
Probably got a more direct answer from Russians than the sensitive Auzzies and left leaning New Zealanders.
How often did you feel
1. Distressed about your sex life 0 1 2 3 4
2. Unhappy about your sexual relationship 0 1 2 3 4
3. Guilty about sexual difficulties 0 1 2 3 4
4. Frustrated by your sexual problems 0 1 2 3 4
5. Stressed about sex 0 1 2 3 4
6. Inferior because of sexual problems 0 1 2 3 4
7. Worried about sex 0 1 2 3 4
8. Sexually inadequate 0 1 2 3 4
9. Regrets about your sexuality 0 1 2 3 4
10. Embarrassed about sexual problems 0 1 2 3 4
11. Dissatisfied with your sex life 0 1 2 3 4
12. Angry about your sex life 0 1 2 3 4
13. Bothered by low sexual desire 0 1 2 3 4
Have fun answering them yourself based on how you feel now and before you invested here.
I've got a nice 400k+ position amd expect a catalysts soon
They are never returning the cash imo but there should be something else to be done. I've just added 65k at 1.975p crazy I'm buying Ovb under 2p when it was 14.5p a week ago
Started: Laura2022, 2 Sep 2023 10:38
Last post: Laura2022, 4 Sep 2023 09:50
I cam see 4p
That will be 3p soon
Can sell 400,000 at 2.25p
Thanks
Perhaps add to your 112 posts on AVCT rather then clog up here
Particularly as the major shareholders are Russian. Oh dear. You couldn't make it up Laura, or should I say Laura Golovanovska.🤣🤣🤣
Started: scmdcyp, 4 Sep 2023 09:05
Last post: scmdcyp, 4 Sep 2023 09:18
Whatever we say it is still oversold it’s worth a lot more than it stands at present.
As at 31 July 2023, Ovoca has an unaudited cash balance of €2.6 million, lets see what they decide to do with that cash pile
"great potential" ...a few days after their trial was a complete failure !
I still hold but keep it real, I think the cash shell route would be the best outcome now
This is a share that has great potential this has to be worth at least 4/5p this is way way oversold and will move up nicely this week.
Started: Laura2022, 3 Sep 2023 11:12
Last post: davey50, 4 Sep 2023 08:56
Laura your posts come across as desperation, a trader who does not want to hold for too long and they are not working. Be patient and see what happens otherwise sell and move to your next day trade.
This has potential to be 4/5p well oversold.
Bargain price to be had here.
Moves soon I think
We are surprised and disappointed that the Study did not have a positive conclusion regarding the superiority of Orenetide versus placebo. The Company now intends to analyse the results from the Study in further detail, including investigating the reasons for potential differences between the Study results and results from previously conducted clinical trials of Orenetide
Started: Moneysponge, 1 Sep 2023 13:06
Last post: davey50, 2 Sep 2023 13:45
Avacta is too big for me I like small caps, I used to have them as low as 13p then they got in on the pharma covid bubble and went nuts.
Ovb does have big shareholders so again at 2p for me it's not worth selling, they might just do something else, plenty of tax losses etc etc so going to hold until hopefully a spike comes along then I will move on
...So Avacta buy two profitable fully trading, going concern businesses with part of the bond money and you don't include any revenues from that or milestone paymenst from major partnerships. LG Chem is taking their product into clinic next year plus Point partnership. You assume no revenue and no partnerships for Pre|cision - just outgoing funcds.
I think you don't really know what you're talking about. AVA6k is a modified existing drug and using models for CoS for drug trials don't really apply...but you alrwady knew that didn't you?...or not?
Uninformed, but willing to spread the word....numpty comes to mind
Just some facts.
Avacta is the company, AVA6000 is the lead product. Loan repayments are quarterly, not monthly. Trial news due soon - good news or even better news. Many ways to raise further cash (all small biopharma companies need constant top-ups unti there is a revenue stream - it's normal!). Those % figures - just meaningless supposition.
Avacta might end up being be a wonderful product but….
£300m mcap, £44M CLN, £40m cash last December so maybe what ~£20-25m cash currently?, monthly issuing of stock to pay bond interest
By default over time It’s going to get hammered in to the ground, might be great for bondholders who pick up cheap equity but the odds are less favourable for holders of existing equity, I’d say 85% chance of a 75%-90% drop there in a year or two when cash runs out and bonds outstanding, 10% chance sp ranges with a downward trend, 5% chance it rises and you get the moon shot RNS but even then for only 3x potential it’s currently priced on the high side, I’d was 5-10x potential.
I know it has its fan clubs but My gut says it inevitably runs out of money and equity screwed, but I do hope it does end favourably, or atleast a product they are involved in comes to market and actually helps people.
As for OVB - just test it again elsewhere, if it works great, it not move on.
Doesnt make me wrong about avacta tho beanevisat
Chance of success is way above 50% for this to become a multi billion pound company
thats a fact.
Crap here but if people are desisive and act fast they can recover all losses and more at avacta
another fact
Started: BuenaVista, 1 Sep 2023 13:54
Last post: BuenaVista, 1 Sep 2023 13:54
It's never nice when you see your money wiped out with your investment so those who have lost out here have my sympathy.
I'd never heard of Ovoca Bio unti I saw yesterday's disastrous RNS. Immediately I knew I'd never ever have invested in this company, and for these reasons:
1. There is only one drug candidate in the pipeline, so the company is a binary play: win big or lose everything.
2. The trials by Ivix were done in Russia. I would never trust anything coming out of Russia. They have a culture of lying: of lying openly, blatantly and straight-facedly. It's called 'vranyo' and it is done for personal progression.
3. Ovoca Bio is based in Ireland and I would never trust an Irish company. Their flavour of lying is called 'blarney'.
I see some are claiming that they've bought more OVB shares at this knockdown price as the SP will be going up again. Don't believe them. (Have they bought or are they trying to get others to buy and thereby raise the price so that they can sell their holding at a better price?) In any case, this company is a dog and is dead in the water. There may be assets in the form of a cash pile but that will dwindle away into the directors' pockets. This company has no product and no future.
Basically you want them to write off the whole drug and become a cash shell then there is hope
I have added more
Results were very fishy, and if the guys inside are shocked and surprised then there is something wrong somewhere hence why investigating results….could well be some big errors or other but need to wait for analysis.
Dr. Daniil Nemenov, SVP for Clinical Development and Operations of Ovoca Bio plc, said: "We are surprised and disappointed that the Study did not have a positive conclusion regarding the superiority of Orenetide versus placebo. The Company now intends to analyse the results from the Study in further detail, including investigating the reasons for potential differences between the Study results and results from previously conducted clinical trials of Orenetide. While we are naturally disappointed with these results, I would like thank all those involved in the Study to date, including the patients who were enrolled, their families, our investigators, staff, and all of the dedicated Ovoca employees."
I should imagine there would be some form of recovery especially that they have cash in the bank. Anyway, lets see what happens in the next few days....GL...
I think most sellers out.
Should see an uptick today Maybe hit 3p.
Then next week a bit more settled must be worth at least 4 to 5 p at present.
Started: Newbee007, 1 Sep 2023 09:26
Last post: Newbee007, 1 Sep 2023 09:26
There surely has to be a small bounce here. a near 90% is too much!
Started: fundamentalanalysis, 1 Sep 2023 08:59
Last post: Laura2022, 1 Sep 2023 09:11
Certainly think it could recover some of the steep drop from 14p
Good time to get in here now, The bottom has been reached and i reckon over 100% to be made in very quick time from here.
Started: Laura2022, 1 Sep 2023 08:31
Last post: Laura2022, 1 Sep 2023 08:45
Apologies
Poor grammar ,my first purchases of today , the £1500 I also had 2 purchases yesterday
Laura2022, you stated you bought yesterday, at 2.8p?
Purchased my first amount today
Started: Sujood, 30 Aug 2023 11:15
Last post: Laura2022, 1 Sep 2023 07:45
€2.6mln
appropriate future strategy regarding the development of Orenetide, including whether the Company should continue with its development of the product, and any implications this may have for the wider strategy of the Company As at 31 July 2023, Ovoca has an unaudited cash balance of €2.6 million
Davey
Sorry to hear about your situation here,what csn they do now witj the £2mln or os funds
Ria is just shamless, a pump and dumper of the highest calibre. No matter what they say about a stock they will not be holding it a few days later. And there's me holding this for 4 years only for that result. Certainly comes across to take anything said in Russia with a pinch a salt. How it is possible to sail through a phase 111 and then completely have no effect in a phase 11 somebody has not told the truth unless it's a completely different drug. .You can see why these pump and dumpers do this sort of thing, no risk they jump in and out and do not have to suffer disasters like this today or suspensions or delisting RNS's that happen to normal folk.
Lol only 4.5k since April....mattlefunk your so spot on...
Definitely someone with 3 or 4 accounts...
Appears genuine enough, member since the start of April and only 4.5k posts.